Showing results (401-410 of 508) with videos related to
Sort By:
Pageof 51
The American Journal of Pathology|June 1, 1997
Differential rescue of the renal and hepatic disease in an autosomal recessive polycystic kidney disease mouse mutant. A new model to study the liver lesionB K Yoder, W G Richards, C Sommardahl, et al.Kidney International|October 1, 1996
Functional correction of renal defects in a mouse model for ARPKD through expression of the cloned wild-type Tg737 cDNAB K Yoder, W G Richards, C Sommardahl, et al.Irish Medical Journal|May 16, 2022
National Guidelines on the Provision of Outpatient Parenteral Antimicrobial Therapy (OPAT)E Sweeney, N Curtin, E de Barra, et al.Journal of Occupational and Environmental Medicine|September 12, 2008
Acute upper and lower respiratory effects in wildland firefightersDenise M Gaughan, Jean M Cox-Ganser, Paul L Enright, et al.The Journal of Biological Chemistry|April 2, 2011
Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expressionClaude A Piantadosi, Crystal M Withers, Raquel R Bartz, et al.Critical Care Medicine|June 23, 2017
Identifying Distinct Subgroups of ICU Patients: A Machine Learning ApproachKelly C Vranas, Jeffrey K Jopling, Timothy E Sweeney, et al.European Journal of Clinical Investigation|January 24, 2023
Multisite validation of a host response signature for predicting likelihood of bacterial and viral infections in patients with suspected influenzaMaryam Shojaei, Uan-I Chen, Uros Midic, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|November 10, 2016
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastomaJuliana Cano-Mejia, Rachel A Burga, Elizabeth E Sweeney, et al.EULAR Rheumatology Open|August 1, 2026
Efficacy and safety of venanprubart, a BTLA agonist antibody, in patients with active systemic lupus erythematosusIndrajit Ghosh, Susan E Sweeney, Brian Moser, et al.Diabetes Care|April 24, 2001
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)J I Barzilay, C L Jones, B R Davis, et al.Pageof 51